Show Summary Details
Page of

Using medications in children 

Using medications in children
Using medications in children

Nigel Ballantine

and Elizabeth Bing Daglish

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 20 January 2020

The term ‘therapeutic orphans’ was coined by H. Shirkey in 1968 when referring to the lack of a sound scientific basis for the delivery of drug treatment to children and neonates. More than four decades later, our understanding of the maturation of physiological processes has undoubtedly grown, enabling drug treatment to be delivered more rationally to children from a more informed position. However, certain groups of children remain therapeutic orphans. This is particularly true of those receiving palliative care. The complexities of the interaction between maturing physiological function, underlying disease, terminal illness, and ethical considerations result in a lack of research data. These difficulties are addressed in the following sections through an examination of the maturation of pharmacokinetic and pharmacodynamic function, and the effect of acute and chronic disease.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.